Skip to main content

Table 5 Treatments of patients infected with COVID-19

From: Identification of risk factors for in-hospital death of COVID - 19 pneumonia -- lessions from the early outbreak

  Total
(n = 156)
Survivor
(n = 100)
Non-survivor
(n = 56)
P valuea
Antibiotics, % 150 (96.2) 96 (96.0) 54 (96.4) 1.000
Antiviral treatment, % 139 (89.1) 89 (89.0) 50 (89.3) 0.956
Corticosteroids, % 60 (38.5) 22 (22.0) 38 (67.9) < 0.001
Intravenous immunoglobulin, % 51 (32.7) 18 (18.0) 33 (58.9) < 0.001
High-flow nasal cannula oxygen therapy, % 56 (35.9) 26 (26.0) 30 (53.6) 0.001
Non-invasive mechanical ventilation, % 44 (28.2) 13 (13.0) 31 (55.4) < 0.001
Invasive mechanical ventilation, % 19 (12.2) 1 (1.0) 18 (32.1) < 0.001
RRT, % 6 (3.8) 1 (1.0) 5 (8.9) 0.023
  1. Notes: Data presented as n (%)
  2. Abbreviations: COVID-19 Coronavirus Disease 2019, RRT Renal replacement therapy
  3. aP values indicate differences between survivors and non-survivors. P < 0.05 was considered statistically significant